285 related articles for article (PubMed ID: 25305317)
41. Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57.
Tang Y; Huang S; Dunkley-Thompson J; Steel-Duncan JC; Ryland EG; St John MA; Hazra R; Christie CD; Feeney ME
AIDS; 2010 Jun; 24(10):1425-35. PubMed ID: 20539088
[TBL] [Abstract][Full Text] [Related]
42. Viral suppression of multiple escape mutants by de novo CD8(+) T cell responses in a human immunodeficiency virus-1 infected elite suppressor.
O'Connell KA; Hegarty RW; Siliciano RF; Blankson JN
Retrovirology; 2011 Aug; 8():63. PubMed ID: 21812985
[TBL] [Abstract][Full Text] [Related]
43. Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele.
Zhang Y; Chikata T; Kuse N; Murakoshi H; Gatanaga H; Oka S; Takiguchi M
J Virol; 2022 Nov; 96(22):e0124822. PubMed ID: 36326273
[TBL] [Abstract][Full Text] [Related]
44. Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection.
Kosmrlj A; Read EL; Qi Y; Allen TM; Altfeld M; Deeks SG; Pereyra F; Carrington M; Walker BD; Chakraborty AK
Nature; 2010 May; 465(7296):350-4. PubMed ID: 20445539
[TBL] [Abstract][Full Text] [Related]
45. Evidence of CD8+ T-cell-mediated selective pressure on human immunodeficiency virus type 1 nef in HLA-B*57+ elite suppressors.
Bailey JR; Brennan TP; O'Connell KA; Siliciano RF; Blankson JN
J Virol; 2009 Jan; 83(1):88-97. PubMed ID: 18945771
[TBL] [Abstract][Full Text] [Related]
46. High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection.
Keane NM; Roberts SG; Almeida CA; Krishnan T; Chopra A; Demaine E; Laird R; Tschochner M; Carlson JM; Mallal S; Heckerman D; James I; John M
Immunol Cell Biol; 2012 Feb; 90(2):224-34. PubMed ID: 21577229
[TBL] [Abstract][Full Text] [Related]
47. CD8+ T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants.
Pohlmeyer CW; Buckheit RW; Siliciano RF; Blankson JN
Retrovirology; 2013 Dec; 10():152. PubMed ID: 24330837
[TBL] [Abstract][Full Text] [Related]
48. Despite biased TRBV gene usage against a dominant HLA B57-restricted epitope, TCR diversity can provide recognition of circulating epitope variants.
Simons BC; Vancompernolle SE; Smith RM; Wei J; Barnett L; Lorey SL; Meyer-Olson D; Kalams SA
J Immunol; 2008 Oct; 181(7):5137-46. PubMed ID: 18802118
[TBL] [Abstract][Full Text] [Related]
49. HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load.
Frahm N; Adams S; Kiepiela P; Linde CH; Hewitt HS; Lichterfeld M; Sango K; Brown NV; Pae E; Wurcel AG; Altfeld M; Feeney ME; Allen TM; Roach T; St John MA; Daar ES; Rosenberg E; Korber B; Marincola F; Walker BD; Goulder PJ; Brander C
J Virol; 2005 Aug; 79(16):10218-25. PubMed ID: 16051815
[TBL] [Abstract][Full Text] [Related]
50. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage.
Chopera DR; Woodman Z; Mlisana K; Mlotshwa M; Martin DP; Seoighe C; Treurnicht F; de Rosa DA; Hide W; Karim SA; Gray CM; Williamson C;
PLoS Pathog; 2008 Mar; 4(3):e1000033. PubMed ID: 18369479
[TBL] [Abstract][Full Text] [Related]
51. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection.
Goulder PJ; Bunce M; Krausa P; McIntyre K; Crowley S; Morgan B; Edwards A; Giangrande P; Phillips RE; McMichael AJ
AIDS Res Hum Retroviruses; 1996 Dec; 12(18):1691-8. PubMed ID: 8959245
[TBL] [Abstract][Full Text] [Related]
52. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition.
Miura T; Brockman MA; Schneidewind A; Lobritz M; Pereyra F; Rathod A; Block BL; Brumme ZL; Brumme CJ; Baker B; Rothchild AC; Li B; Trocha A; Cutrell E; Frahm N; Brander C; Toth I; Arts EJ; Allen TM; Walker BD
J Virol; 2009 Mar; 83(6):2743-55. PubMed ID: 19116253
[TBL] [Abstract][Full Text] [Related]
53. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection.
Chen H; Ndhlovu ZM; Liu D; Porter LC; Fang JW; Darko S; Brockman MA; Miura T; Brumme ZL; Schneidewind A; Piechocka-Trocha A; Cesa KT; Sela J; Cung TD; Toth I; Pereyra F; Yu XG; Douek DC; Kaufmann DE; Allen TM; Walker BD
Nat Immunol; 2012 Jun; 13(7):691-700. PubMed ID: 22683743
[TBL] [Abstract][Full Text] [Related]
54. T-Cell Receptor (TCR) Clonotype-Specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T-Cell Clones Is Not Mediated by TCR Alone.
Flerin NC; Chen H; Glover TD; Lamothe PA; Zheng JH; Fang JW; Ndhlovu ZM; Newell EW; Davis MM; Walker BD; Goldstein H
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077649
[TBL] [Abstract][Full Text] [Related]
55. CD8+ TCR Bias and Immunodominance in HIV-1 Infection.
Kløverpris HN; McGregor R; McLaren JE; Ladell K; Harndahl M; Stryhn A; Carlson JM; Koofhethile C; Gerritsen B; Keşmir C; Chen F; Riddell L; Luzzi G; Leslie A; Walker BD; Ndung'u T; Buus S; Price DA; Goulder PJ
J Immunol; 2015 Jun; 194(11):5329-45. PubMed ID: 25911754
[TBL] [Abstract][Full Text] [Related]
56. HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor.
Dong T; Stewart-Jones G; Chen N; Easterbrook P; Xu X; Papagno L; Appay V; Weekes M; Conlon C; Spina C; Little S; Screaton G; van der Merwe A; Richman DD; McMichael AJ; Jones EY; Rowland-Jones SL
J Exp Med; 2004 Dec; 200(12):1547-57. PubMed ID: 15596521
[TBL] [Abstract][Full Text] [Related]
57. Immunodominant HIV-1-specific HLA-B- and HLA-C-restricted CD8+ T cells do not differ in polyfunctionality.
Mkhwanazi N; Thobakgale CF; van der Stok M; Reddy S; Mncube Z; Chonco F; Walker BD; Altfeld M; Goulder PJ; Ndung'u T
Virology; 2010 Sep; 405(2):483-91. PubMed ID: 20638093
[TBL] [Abstract][Full Text] [Related]
58. Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection.
Lopes AR; Jaye A; Dorrell L; Sabally S; Alabi A; Jones NA; Flower DR; De Groot A; Newton P; Lascar RM; Williams I; Whittle H; Bertoletti A; Borrow P; Maini MK
J Immunol; 2003 Jul; 171(1):307-16. PubMed ID: 12817012
[TBL] [Abstract][Full Text] [Related]
59. Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control.
Murakoshi H; Koyanagi M; Akahoshi T; Chikata T; Kuse N; Gatanaga H; Rowland-Jones SL; Oka S; Takiguchi M
EBioMedicine; 2018 Oct; 36():103-112. PubMed ID: 30249546
[TBL] [Abstract][Full Text] [Related]
60. Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure.
Ngumbela KC; Day CL; Mncube Z; Nair K; Ramduth D; Thobakgale C; Moodley E; Reddy S; de Pierres C; Mkhwanazi N; Bishop K; van der Stok M; Ismail N; Honeyborne I; Crawford H; Kavanagh DG; Rousseau C; Nickle D; Mullins J; Heckerman D; Korber B; Coovadia H; Kiepiela P; Goulder PJ; Walker BD
AIDS Res Hum Retroviruses; 2008 Jan; 24(1):72-82. PubMed ID: 18275350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
